Skip to content

Efficacy comparison of intensive acute phoniatric intervention (IPA), voice therapy and psychotherapy for dissociative voice disorder (aphonia and dysphonia)

Efficacy comparison of intensive acute phoniatric intervention (IPA), voice therapy and psychotherapy for dissociative voice disorder (aphonia and dysphonia) - DissVoice

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035098
Enrollment
76
Registered
2024-10-08
Start date
2025-03-25
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F44.4 R49.1

Interventions

Group 1: This study arm is part of the prospective, randomised, controlled comparative therapy study. In arm 1, patients receive the intensive phoniatric acute intervention (IPA) for dissociative voic

Sponsors

Universitätsklinikum Münster (UKM), Klinik für Phoniatrie und Pädaudiologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 69 Years

Inclusion criteria

Inclusion criteria: All participants: - are between 18 and 69 years old - use German as their first or main language - have right-handedness Patients with dissociative voice disorders: - have a diagnosed dissociative voice disorder (psychogenic dysphonia/aphonia) - have already received speech therapy treatment of at least 10 therapy hours

Exclusion criteria

Exclusion criteria: All participants: - left-handedness, ambidexterity (using the Edinburgh handedness questionnaire (EHI)) - motor, cognitive, anatomical or sensory disorders that may be associated with speech and voice deficits - speech fluency disorder (stuttering, poluttering) - profound developmental disorder (e.g. autism) and severe congenital somatic diseases - pre-existing severe concomitant mental illness (schizophrenia, history of psychotic episode, severe depressive episode, post-traumatic stress disorder, bipolar disorder, personality disorder according to DSM-V, current or history of substance-related addiction) - severe cognitive disorder (delirium, dementia) - central nervous system medication taken within the last 3 months - acute influence of psychoactive substances (alcohol, cannabis, etc.) at the time of the study - MRI contraindications (e.g. metallic objects in/on the body, pregnancy, breastfeeding, claustrophobia) Patients with dissociative voice disorders: - existence of dysphonia / aphonia for more than 2 years - ongoing speech therapy - previous psychotherapy within the last 5 years or > 30 hours of psychotherapy

Design outcomes

Primary

MeasureTime frame
Study arm 1 and 2: phoniatric variables according to the extended protocol of the European Laryngological Society Study arm 3: change in the voice quality and voice sound perceived by the patients

Secondary

MeasureTime frame
Study arm 1 and 2: - phoniatric variables: acoustic analysis, aerodynamic analysis, videolaryngostroboscopy, subjective voice quality - psychiatric variables: quality of life, general stress symptoms and disorders (e.g. dissociative disorders, somatization, post-traumatic stress disorder) - ROI in fMRI and MRS (MR-spectroscopy) Study arm 3: relapses, remaining need for treatment, subjective voice quality, influence on everyday life, perception of the therapy received and satisfaction with the intervention received

Countries

Germany

Contacts

Public ContactPhilipp Mathmann

Universitätsklinikum Münster (UKM), Klinik für Phoniatrie und Pädaudiologie

philipp.mathmann@ukmuenster.de0251 / 83 - 598 10

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026